Paracetamol-Tramadol and Paracetamol-caffeine Versus Placebo in the Emergency Discharge Treatment of Renal Colic

ConditionRenal Colic
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-99
SponsorUniversity of Monastir

About this trial

This is a prospective, randomized, single-blind study. Patients included in the study after successful treatment of the acute attack were randomized upon discharge from the Emergency Department into three groups: oral paracetamol-tramadol group, oral paracetamol-caffeine group and oral placebo group.

Eligibility criteria

Qualifiers

-Age > 18 years old.

Consent to participate in the study.

Pain in the flank/lumbar fossa of sudden onset with urine strips and/or imaging corresponding to the diagnosis of renal colic.

Pain score at discharge < 30 (visual analog scale - VAS or verbal numerical scale - VAS from 0 to 100).

Disqualifiers

-Inability to appreciate pain according to the VAS.

Pregnant or breastfeeding woman.

Renal insufficiency with creatinine clearance < 60 ml/min.

Trial design

Treatments tested in this trial

  • paracétamol tramadol
  • Paracétamol cafeine
  • Placebo

Treatment groups

1,500 Participants
are divided into 3 treatment groups

Sponsors and collaborators